{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T08:38:00Z","timestamp":1791016680384,"version":"4.1.0"},"reference-count":94,"publisher":"The Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glucocorticoids are known to play a role in the regulation of peripheral glucose mobilization and metabolism. Although several animal studies have shown that hippocampal glucose metabolism is reduced acutely and chronically by the action of corticosterone and that excess glucocorticoids are harmful to hippocampal neurons, little is known about the central effects of glucocorticoids in the human. In this study we examined the brain glucose utilization (CMRglu) response to hydrocortisone (cortisol) in seven normal elderly and eight Alzheimer\u2019s disease (AD) patients. On 2 separate days, immediately after the administration of a bolus of either 35 mg hydrocortisone or placebo, we administered 2-deoxy-2-[18F]fluoro-d-glucose. After a 35-min radiotracer uptake period, positron emission tomography (PET) images were collected. PET CMRglu images were analyzed using two methods: an image transformation that allowed analyses across cases on a voxel by voxel basis, and an anatomically based region of interest method that used coregistered magnetic resonance imaging scans. Both image analysis methods yielded similar results, identifying relative to placebo, a specific hippocampal CMRglu reduction in response to the hydrocortisone challenge that was restricted to the normal group. The region of interest technique showed CMRglu reductions of 16% and 12% in the right and left hippocampi, respectively. Blood collected during the PET scans showed, for the normal group, a rise in plasma glucose levels, starting approximately 25 min after hydrocortisone administration. The AD group did not show this effect. Baseline cortisol was elevated in the AD group, but the clearance of hydrocortisone was not different between the groups. In conclusion, these data show that among normal individuals in the presence of a pharmacological dose of cortisol, the glucose utilization of the hippocampus is specifically reduced, and serum glucose levels increase. Based in part on other studies, we offer the interpretation that glucocorticoid-mediated regulation of glucose transport is altered in AD, and this may underlie both the hippocampal insensitivity to cortisol and the failure in these patients to mount a peripheral glucose response. As our findings could reflect an altered state of the AD patients, we interpret our results as preliminary with respect to evidence for metabolic abnormalities in AD. The results suggest the continued study of the hydrocortisone challenge as a test of hippocampal responsivity.<\/jats:p>","DOI":"10.1210\/jcem.82.10.4305","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:01:22Z","timestamp":1389200482000},"page":"3251-3259","source":"Crossref","is-referenced-by-count":4,"title":["Cortisol Reduces Hippocampal Glucose Metabolism in Normal Elderly, but Not in Alzheimer\u2019s Disease*"],"prefix":"10.1210","volume":"82","author":[{"given":"M. J.","family":"de Leon","sequence":"first","affiliation":[{"name":"Departments of Psychiatry (M.J.deL., A.C., S.D.S., C.T., K.D.), New York, New York"},{"name":"Nathan Kline Institute for Psychiatric Research (M.J.deL., A.C.), Orangeburg, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"McRae","sequence":"additional","affiliation":[{"name":"Medicine (T.M.), New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Rusinek","sequence":"additional","affiliation":[{"name":"Radiology (H.R.), New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Convit","sequence":"additional","affiliation":[{"name":"Departments of Psychiatry (M.J.deL., A.C., S.D.S., C.T., K.D.), New York, New York"},{"name":"Nathan Kline Institute for Psychiatric Research (M.J.deL., A.C.), Orangeburg, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"De Santi","sequence":"additional","affiliation":[{"name":"Departments of Psychiatry (M.J.deL., A.C., S.D.S., C.T., K.D.), New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Tarshish","sequence":"additional","affiliation":[{"name":"Departments of Psychiatry (M.J.deL., A.C., S.D.S., C.T., K.D.), New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Golomb","sequence":"additional","affiliation":[{"name":"Neurology (J.G.), New York University Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Volkow","sequence":"additional","affiliation":[{"name":"Departments of Chemistry and Medicine, Brookhaven National Laboratory (N.V.), Upton, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Daisley","sequence":"additional","affiliation":[{"name":"Departments of Psychiatry (M.J.deL., A.C., S.D.S., C.T., K.D.), New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Orentreich","sequence":"additional","affiliation":[{"name":"Dermatology (N.O.), New York, New York"},{"name":"Orentreich Foundation for the Advancement of Science (N.O.), Coldspring, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"McEwen","sequence":"additional","affiliation":[{"name":"Laboratory of Neuroendocrinology, Rockefeller University (B.M.), New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071615450128900_R1","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1172\/JCI111227","article-title":"Increased proteo-lysis. An effect of increases in plasma cortisol within the physiologic range.","volume":"73","author":"Simmons","year":"1984","journal-title":"J Clin Invest"},{"key":"2020071615450128900_R2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1353\/pbm.1971.0002","article-title":"Glucocorticoid inhibition of glucose uptake by peripheral tissues: old and new evidence, molecular mechanisms, and physiological significance.","volume":"14","year":"1971","journal-title":"Perspect Biol Med"},{"key":"2020071615450128900_R3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1210\/jcem-50-3-495","article-title":"The influence of acute physiological increments of cortisol on fuel metabolism and insulin binding to monocytes in normal humans.","volume":"50","author":"Shamoon","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615450128900_R4","doi-asserted-by":"crossref","first-page":"17696","DOI":"10.1016\/S0021-9258(18)45435-X","article-title":"Dexamethasone causes translocation of glucose transporters from the plasma membrane to an intracellular site in human fibroblasts.","volume":"262","author":"Horner","year":"1987","journal-title":"J Biol Chem"},{"key":"2020071615450128900_R5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000125539","article-title":"Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia.","volume":"52","author":"Horner","year":"1990","journal-title":"Neuroendocrinology"},{"key":"2020071615450128900_R6","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1471-4159.1991.tb08309.x","article-title":"Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: implications for glucocorticoid neurotoxicity.","volume":"57","author":"Virgin","year":"1991","journal-title":"J Neurochem"},{"key":"2020071615450128900_R7","first-page":"119","article-title":"Regional net uptake of 14C-glucose by rat brain under the influence of corticosterone.","volume":"12","author":"Landgraf","year":"1978","journal-title":"Endocrinol Exp"},{"key":"2020071615450128900_R8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0006-8993(92)91634-Q","article-title":"Adrenalectomy or metyrapone-pretreatment abolishes cerebral metabolic responses to the serotonin agonist 1-(2, 5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the hippocampus.","volume":"586","author":"Freo","year":"1992","journal-title":"Brain Res"},{"key":"2020071615450128900_R9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000124933","article-title":"Local cerebral glucose utilization is increased in acutely adrenalectomized rats.","volume":"47","author":"Kadekaro","year":"1988","journal-title":"Neuroendocrinology"},{"key":"2020071615450128900_R10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00374770","article-title":"Adrenalectomy increases local cerebral blood flow in the rat hippocampus.","volume":"426","author":"Endo","year":"1994","journal-title":"Pflugers Arch"},{"key":"2020071615450128900_R11","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1210\/edrv-7-3-284","article-title":"The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis.","volume":"7","author":"Sapolsky","year":"1986","journal-title":"Endocr Rev"},{"key":"2020071615450128900_R12"},{"key":"2020071615450128900_R13","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1523\/JNEUROSCI.09-05-01705.1989","article-title":"Hippocampal damage associated with prolonged and fatal stress in primates.","volume":"9","author":"Uno","year":"1989","journal-title":"J Neurosci"},{"key":"2020071615450128900_R14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0163-1047(93)90173-F","article-title":"Cognitive deficits induced in young rats by long-term corticosterone administration.","volume":"60","author":"Dachir","year":"1996","journal-title":"Behav Neural Biol"},{"key":"2020071615450128900_R15","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.715460","article-title":"Hippocampal aging and adrenocorticoids: quantitative correlations.","volume":"202","author":"Landfield","year":"1978","journal-title":"Science"},{"key":"2020071615450128900_R16","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1159\/000124561","article-title":"Glucocorticoid toxicity in the hippocampus.","volume":"43","year":"1986","journal-title":"Neuroendocrinology"},{"key":"2020071615450128900_R17","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1523\/JNEUROSCI.06-08-02240.1986","article-title":"Glucocorticoid toxicity in the hippocampus: reversal by supplementation with brain fuels.","volume":"6","year":"1986","journal-title":"J Neurosci"},{"key":"2020071615450128900_R18","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1192\/bjp.165.5.650","article-title":"The function of the hypothalamic-pituitary-adrenal axis in Alzheimer\u2019s disease.","volume":"165","author":"O\u2019Brien","year":"1994","journal-title":"Br J Psychiatry"},{"key":"2020071615450128900_R19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0531-5565(94)00065-B","article-title":"Individual differences in hypothalamic-pituitary-adrenal activity in later life and hippocampal aging.","volume":"30","author":"Meaney","year":"1995","journal-title":"Exp Gerontol"},{"key":"2020071615450128900_R20","first-page":"666","article-title":"Dementia, ageing, and the stress control system.","volume":"345","year":"1996","journal-title":"Lancet"},{"key":"2020071615450128900_R21","author":"Leon","year":"1988"},{"key":"2020071615450128900_R22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1176\/ajp.143.3.300","article-title":"Cortisol and Alzheimer\u2019s disease. I. Basal studies.","volume":"143","author":"Davis","year":"1986","journal-title":"Am J Psychiatry"},{"key":"2020071615450128900_R23","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1365-2826.1994.tb00635.x","article-title":"Increased cortisol levels in aging and Alzheimer\u2019s disease in postmortem cerebrospinal fluid.","volume":"6","author":"Swaab","year":"1994","journal-title":"J Neuroendocrinol"},{"key":"2020071615450128900_R24","author":"Raskind","year":"1994"},{"key":"2020071615450128900_R25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000116984","article-title":"Staging of Alzheimer-related cortical destruction.","volume":"33","author":"Braak","year":"1993","journal-title":"Eur Neurol"},{"key":"2020071615450128900_R26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1037\/0033-295X.99.2.195","article-title":"Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans.","volume":"99","year":"1992","journal-title":"Psychol Rev"},{"key":"2020071615450128900_R27","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1176\/ajp.147.10.1297","article-title":"Cognitive effects of corticosteroids.","volume":"147","author":"Wolkowitz","year":"1990","journal-title":"Am J Psychiatry"},{"key":"2020071615450128900_R28","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1523\/JNEUROSCI.14-04-02047.1994","article-title":"Glucocorticoid-induced impairment in declarative memory performance in adult humans.","volume":"14","author":"Newcomer","year":"1994","journal-title":"J Neurosci"},{"key":"2020071615450128900_R29","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0028-3932(89)90096-1","article-title":"Glucose enhancement of performance on memory tests in young and aged humans.","volume":"27","author":"Hall","year":"1989","journal-title":"Neuropsychologia"},{"key":"2020071615450128900_R30","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1037\/0735-7044.107.6.926","article-title":"Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study.","volume":"107","author":"Craft","year":"1993","journal-title":"Behav Neurosci"},{"key":"2020071615450128900_R31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0197-4580(93)90034-9","article-title":"Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer\u2019s type.","volume":"14","author":"Manning","year":"1993","journal-title":"Neurobiol Aging"},{"key":"2020071615450128900_R32","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease.","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"2020071615450128900_R33","year":"1987"},{"key":"2020071615450128900_R34","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ana.410070516","article-title":"Pathological verification of ischemia score in differentiation of dementias.","volume":"7","author":"Rosen","year":"1980","journal-title":"Ann Neurol"},{"key":"2020071615450128900_R35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression.","volume":"23","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2020071615450128900_R36","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","article-title":"The Global Deterioration Scale for assessment of primary degenerative dementia.","volume":"139","author":"Reisberg","year":"1982","journal-title":"Am J Psychiatry"},{"key":"2020071615450128900_R37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state: a practical method for grading the cognitive state of patients for the clinician.","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatry Res"},{"key":"2020071615450128900_R38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/geronj\/26.1.70","article-title":"Patterns of declining memory.","volume":"26","author":"Gilbert","year":"1971","journal-title":"J Gerontol"},{"key":"2020071615450128900_R39","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2466\/pms.1968.27.1.277","article-title":"A preliminary report on a new memory scale.","volume":"27","author":"Gilbert","year":"1968","journal-title":"Percept Mot Skills"},{"key":"2020071615450128900_R40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/jcbfm.1985.24","article-title":"Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18F]fluorodeoxyglucose and[ 11C]deoxyglucose.","volume":"5","author":"Reivich","year":"1985","journal-title":"J Cereb Blood Flow Metab"},{"key":"2020071615450128900_R41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00004728-198901000-00004","article-title":"Accurate three-dimensional registration of CT, PET, and\/or MR images of the brain.","volume":"13","author":"Pelizzari","year":"1989","journal-title":"J Comput Assist Tomogr"},{"key":"2020071615450128900_R42","first-page":"2019","article-title":"Principal axes and surface fitting methods for three-dimensional image registration.","volume":"34","author":"Rusinek","year":"1993","journal-title":"J Nucl Med"},{"key":"2020071615450128900_R43","first-page":"216","article-title":"Quantitation of the human basal ganglia with positron emission tomography: a phantom study of the effect of contrast and axial positioning.","volume":"10","author":"Bendriem","year":"1991","journal-title":"IEEE Trans Nucl Sci"},{"key":"2020071615450128900_R44","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/archneur.1992.00530350056020","article-title":"Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer\u2019s disease: pathophysiologic implications.","volume":"49","author":"Smith","year":"1992","journal-title":"Arch Neurol"},{"key":"2020071615450128900_R45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/jcbfm.1982.15","article-title":"Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F] fluorodeoxyglucose method.","volume":"2","author":"Kuhl","year":"1982","journal-title":"J Cereb Blood Flow Metab"},{"key":"2020071615450128900_R46","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0197-4580(87)90070-4","article-title":"Positron emission tomography studies of normal aging: a replication of PET III and 18-FDG using PET VI and 11-C-2DG.","volume":"8","author":"Leon","year":"1987","journal-title":"Neurobiol Aging"},{"key":"2020071615450128900_R47","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00004728-199507000-00006","article-title":"Preserved pontine glucose metabolism in Alzheimer\u2019s disease: a reference region for functional brain image (PET) analysis.","volume":"19","author":"Minoshima","year":"1995","journal-title":"J Comput Assist Tomogr"},{"key":"2020071615450128900_R48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/hbm.460010103","article-title":"Three-dimensional analysis of clustered voxels in O-15-butanol brain activation images.","volume":"1","author":"Roland","year":"1993","journal-title":"Hum Brain Mapping"},{"key":"2020071615450128900_R49","author":"Baxter","year":"1987"},{"key":"2020071615450128900_R50","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1126\/science.172.3981.394","article-title":"Telemetered recording of hormone effects on hippocampal neurons.","volume":"172","author":"Pfaff","year":"1971","journal-title":"Science"},{"key":"2020071615450128900_R51","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0006-8993(86)90007-7","article-title":"Corticosterone reduces the excitability of hippocampal pyramidal cells in vitro.","volume":"383","author":"Vidal","year":"1986","journal-title":"Brain Res"},{"key":"2020071615450128900_R52","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF01064929","article-title":"Hippocampal atrophy in early Alzheimer\u2019s disease: anatomic specificity and validation.","volume":"64","author":"Convit","year":"1993","journal-title":"Psychiatr Q"},{"key":"2020071615450128900_R53","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/hipo.450020409","article-title":"Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation.","volume":"2","author":"Diamond","year":"1992","journal-title":"Hippocampus"},{"key":"2020071615450128900_R54","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0006-8993(89)91505-9","article-title":"Impaired up-regulation of type II corticosteroid receptors in hippocampus of aged rats.","volume":"478","author":"Eldridge","year":"1989","journal-title":"Brain Res"},{"key":"2020071615450128900_R55","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1523\/JNEUROSCI.09-09-03237.1989","article-title":"Apparent age-related resistance of type II hippocampal corticosteroid receptors to down-regulation during chronic escape training.","volume":"9","author":"Eldridge","year":"1989","journal-title":"J Neurosci"},{"key":"2020071615450128900_R56","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0014-4886(89)90153-2","article-title":"Increased affinity of type II corticosteroid binding in aged rat hippocampus.","volume":"106","author":"Landfield","year":"1989","journal-title":"Exp Neurol"},{"key":"2020071615450128900_R57","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0006-8993(95)00230-N","article-title":"Glucocorticoid receptor mRNA in Alzheimer\u2019s diseased hippocampus.","volume":"679","author":"Wetzel","year":"1995","journal-title":"Brain Res"},{"key":"2020071615450128900_R58","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0197-4580(91)90055-O","article-title":"Elevated urinary free cortisol in patients with dementia.","volume":"12","author":"Maeda","year":"1991","journal-title":"Neurobiol Aging"},{"key":"2020071615450128900_R59","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1600-0404.1990.tb00994.x","article-title":"Dementia of the Alzheimer type and hypothalamus-pituitary-adrenocortical axis: changes in cerebrospinal fluid corticotropin releasing factor and plasma cortisol levels.","volume":"81","author":"Martignoni","year":"1990","journal-title":"Acta Neurol Scand"},{"key":"2020071615450128900_R60","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0306-4530(94)00054-E","article-title":"A subtle disturbance in the feedback regulation of the hypothalamic-pituitary-adrenal axis in the early phase of Alzheimer\u2019s disease.","volume":"20","author":"Nasman","year":"1995","journal-title":"Psychoneuroendocrinology"},{"key":"2020071615450128900_R61","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ana.410350507","article-title":"Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer\u2019s disease.","volume":"35","author":"Simpson","year":"1994","journal-title":"Ann Neurol"},{"key":"2020071615450128900_R62","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00005072-199501000-00005","article-title":"Functional alterations in Alzheimer\u2019s disease: decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone.","volume":"54","author":"Harr","year":"1995","journal-title":"J Neuropathol Exp Neurol"},{"key":"2020071615450128900_R63","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/jcbfm.1991.65","article-title":"Diminished glucose transport in Alzheimer\u2019s disease: dynamic PET studies.","volume":"11","author":"Jagust","year":"1991","journal-title":"J Cereb Blood Flow Metab"},{"key":"2020071615450128900_R64","first-page":"202","article-title":"Diminished glucose transport and phosphorylation in Alzheimer\u2019s disease determined by dynamic FDG-PET.","volume":"37","author":"Piert","year":"1996","journal-title":"J Nucl Med"},{"key":"2020071615450128900_R65","doi-asserted-by":"crossref","first-page":"24678","DOI":"10.1074\/jbc.270.42.24678","article-title":"The insulin-dependent biosynthesis of GLUT1 and GLUT3 glucose transporters in L6 muscle cells is mediated by distinct pathways.","volume":"270","author":"Taha","year":"1995","journal-title":"J Biol Chem"},{"key":"2020071615450128900_R66","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1172\/JCI116424","article-title":"Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo.","volume":"91","author":"Giorgino","year":"1993","journal-title":"J Clin Invest"},{"key":"2020071615450128900_R67","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1210\/endo.136.4.7895667","article-title":"Insulin and dexamethasone regulate insulin receptors, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in fao hepatoma cells.","volume":"136","author":"Saad","year":"1995","journal-title":"Endocrinology"},{"key":"2020071615450128900_R68","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2337\/diab.44.4.441","article-title":"Glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin- and non-insulin-related stimuli.","volume":"44","author":"Weinstein","year":"1995","journal-title":"Diabetes"},{"key":"2020071615450128900_R69","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/mrm.1910080210","article-title":"Quantitative NMR measurements of hippocampal atrophy in Alzheimer\u2019s disease.","volume":"8","author":"Seab","year":"1988","journal-title":"Magn Reson Med"},{"key":"2020071615450128900_R70","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1212\/WNL.41.1.51","article-title":"Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer\u2019s disease.","volume":"41","author":"Kesslak","year":"1991","journal-title":"Neurology"},{"key":"2020071615450128900_R71","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1212\/WNL.42.1.183","article-title":"MR-based hippocampal volumetry in the diagnosis of Alzheimer\u2019s disease.","volume":"42","author":"Jack","year":"1992","journal-title":"Neurology"},{"key":"2020071615450128900_R72","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0006-3223(91)90211-4","article-title":"Cerebral structure on MRI. II. Specific changes in Alzheimer\u2019s and Huntington\u2019s diseases.","volume":"29","author":"Jernigan","year":"1991","journal-title":"Biol Psychiatry"},{"key":"2020071615450128900_R73","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/jnnp.58.5.590","article-title":"Memory disorders in probable Alzheimer\u2019s disease: the role of hippocampal atrophy as shown with MRI.","volume":"58","author":"Deweer","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2020071615450128900_R74","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00599184","article-title":"MRI-based quantitative assessment of the hippocampal region in very mild to moderate Alzheimer\u2019s disease.","volume":"36","author":"Ikeda","year":"1994","journal-title":"Neuroradiology"},{"key":"2020071615450128900_R75","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02252964","article-title":"Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer\u2019s disease: correlation with memory functions.","volume":"9","author":"Laakso","year":"1995","journal-title":"J Neural Transm"},{"key":"2020071615450128900_R76","first-page":"929","article-title":"Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease.","volume":"15","author":"Lehericy","year":"1994","journal-title":"Am J Neuroradiol"},{"key":"2020071615450128900_R77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0197-4580(97)00001-8","article-title":"Specific hippocampal volume reductions in individuals at risk for Alzheimer\u2019s disease.","volume":"18","author":"Convit","year":"1997","journal-title":"Neurobiol Aging"},{"key":"2020071615450128900_R78"},{"key":"2020071615450128900_R79","first-page":"897","article-title":"The radiologic prediction of Alzheimer\u2019s disease: the atrophic hippocampal formation.","volume":"14","author":"Leon","year":"1993","journal-title":"Am J Neuroradiol"},{"key":"2020071615450128900_R80"},{"key":"2020071615450128900_R81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0197-4580(96)00213-8","article-title":"Frequency of hippocampus atrophy in normal elderly and Alzheimer\u2019s disease patients.","volume":"18","author":"Leon","year":"1997","journal-title":"Neurobiol Aging"},{"key":"2020071615450128900_R82","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1212\/WNL.38.6.909","article-title":"Longitudinal studies of regional cerebral metabolism in Alzheimer\u2019s disease.","volume":"38","author":"Jagust","year":"1988","journal-title":"Neurology"},{"key":"2020071615450128900_R83","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0006-3223(95)00590-0","article-title":"The predictive value of hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer\u2019s disease.","volume":"39","author":"Swanwick","year":"1996","journal-title":"Soc Biol Psychiatry"},{"key":"2020071615450128900_R84","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1523\/JNEUROSCI.14-05-02893.1994","article-title":"Basal cortisol levels and cognitive deficits in human aging.","volume":"14","author":"Lupien","year":"1994","journal-title":"J Neurosci"},{"key":"2020071615450128900_R85","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(94)92338-8","article-title":"Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer\u2019s disease.","volume":"344","author":"West","year":"1994","journal-title":"Lancet"},{"key":"2020071615450128900_R86","first-page":"205","article-title":"Atrophy of hippocampal formation subdivisions correlates with stage and duration of Alzheimer disease.","volume":"6","author":"Bobinski","year":"1995","journal-title":"Dementia"},{"key":"2020071615450128900_R87","first-page":"909","article-title":"Neurofibrillary pathology\u2013correlation with hippocampal formation atrophy in Alzheimer disease.","volume":"17","author":"Bobinski","year":"1996","journal-title":"Neurobiol Aging"},{"key":"2020071615450128900_R88","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","article-title":"Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer\u2019s disease.","volume":"16","author":"Gomez-Isla","year":"1996","journal-title":"J Neurosci"},{"key":"2020071615450128900_R89","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0006-3223(92)90204-D","article-title":"Paradoxical effects of adrenal steroids on the brain: protection versus degeneration.","volume":"31","author":"McEwen","year":"1992","journal-title":"Biol Psychiatry"},{"key":"2020071615450128900_R90","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000118985","article-title":"Quantitative electroencephalographic correlates of steroid administration in man.","volume":"27","author":"Wolkowitz","year":"1993","journal-title":"Neuropsychobiology"},{"key":"2020071615450128900_R91","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/0006-3223(92)90079-F","article-title":"Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing\u2019s syndrome.","volume":"32","author":"Starkman","year":"1992","journal-title":"Biol Psychiatry"},{"key":"2020071615450128900_R92","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0165-1781(93)90046-J","article-title":"Hypercortisolemia and hippocampal changes in depression.","volume":"47","author":"Axelson","year":"1993","journal-title":"Psychiatry Res"},{"key":"2020071615450128900_R93","first-page":"57","article-title":"Altered cortisol response and the hippocampal atrophy in pediatric HIV disease.","volume":"7","author":"Oberfield","year":"1996","journal-title":"J AIDS"},{"key":"2020071615450128900_R94","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1212\/WNL.47.6.1396","article-title":"The effect on memory of chronic prednisone treatment in patients with systemic disease.","volume":"47","author":"Keenan","year":"1996","journal-title":"Neurology"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/82\/10\/3251\/9041043\/jcem3251.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/82\/10\/3251\/9041043\/jcem3251.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T23:41:47Z","timestamp":1647906107000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/82\/10\/3251\/2823196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10,1]]},"references-count":94,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1997,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.82.10.4305","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,10,1]]}}}